Home / Catalog / Drugs & devices

Drugs & devicesSource-backed product

IRA Maximum Fair Price (CMS-negotiated)

The maximum fair prices CMS has negotiated for selected high-cost drugs under the Inflation Reduction Act, effective 2026 and 2027. The first federally negotiated Medicare drug prices.

What Vlada adds: Preserves the publisher data, normalizes schema eras and identifiers, and connects the product to compatible healthcare entities with measured join coverage.

rows
386
rows
datasets
1
datasets
cadence
annual
cadence
coverage
2026-2027
coverage

Publishers: Centers for Medicare & Medicaid Services

What's inside

Primary dataset
CMS Inflation-Reduction-Act negotiated maximum fair prices.
grain: One row per (NDC11, program_year) negotiated MFP.
386 rows